We are delighted to share with you the work carried out by physicians and patient partners on the feelings of patients with peritoneal surface malignancies.
@AssocAmarape @liguecancer @bigrenape. @MartinHbner3 @oliviawriting @ClaEveno @CHULimoges academic.oup.com/bjs/advance…
efficacy of chemo treatment did not differ between the metastatic sites!
Effect of 5-FU+ Oxali on the histological response of PEeritoneal and hePatIc colorectal metasTases in a mOuse model: PEPITO experimental study @CNRS @CHULimoges @ejsotweets
doi.org/10.1016/j.ejso.2022.…
AT retweeted
1 week to go for 1st Middle East @PSOGI_EC Dr @oliviawriting is inviting you to join our Congress in #Jeddah in person or virtually for registration: psogi-me.ksau-hs.edu.sa join us to learn from the best @DeliaCortesGuir @RENAPE_Network @glehenolivier @SWexner @juliomayol
AT retweeted
To start the week well, we are announcing our @ESSOnews course on the management of colorectal metastatic disease in September. Registration is now open and everything you need is on the website
essoweb.org/courses/esso-cou…
@RENAPE_Network @PSOGI_EC @ISSPP1 @hpb_so @SPeritoneum
AT retweeted
Le registre des #essaiscliniques en cancérologie menés en France contient des protocoles d’essais cliniques sous forme de résumés destinés aux patients et des informations scientifiques plus détaillées pour les professionnels. Consulter : bit.ly/3Wy9DH0
AT retweeted
I was so eager to hear more about it that I thought it was today 😁 but it is going to be on January, the 20th. Save the date! @somusp9 @AT_surgery @sanket86024322 @CashinPtr @acpmpresearch @FaheezM @GECOP_ @drarturreis @hsalvadorcr1
This Post is from an account that no longer exists. Learn more
AT retweeted
Revised schedule: 9th Dec Fri
10-11am EST
4-5pm CET
3-4pm GMT
8.30-9.30pm 🇮🇳
1-2pm 🇧🇷
@gyncsm @Bhandoria @IndiraRosero @drsadiejones @dr_ray2 @Elizabeth_Tremb @Some4SurgeryIT1 @CNevrez @BatistaTP @AT_surgery @docswapnil01 @SPeritoneum @cascalescirugia @ghanim_khatib @alarjosan
#CASEofthemonth #12
with @PSugarbaker
❇️Interval CRS for advanced ovarian cancer -technical nuances❇️
🗓️Friday-2nd Dec '22
10-11am EST
4-5pm CET
3-4pm GMT
8.30-9.30pm🇮🇳
1-2pm🇧🇷
@SPeritoneum @MISIRG1 @Some4SurgeryIT1
@gyncsm @GynMe4 @ENYGO_official @gynoncjnls
@ESGO_society
Not easy to speak after @Thom_astro at FRENCh surgical congrès SFCD-ACHBT. 😱 Results of biliary drainage before pancreatectomy: comparative study / LAMS versus ERCP @lachbt @SFED_Endoscopie
Predictive value of CRP after CRS and HIPEC @FrontOncology @AT_surgery @CHULimoges #HIPEC #inflammation #Peritonealmetastasis
AT retweeted
PLUS study results just published!!! Best lecture for your Sunday breakfast…
⭐️ #PIPAC can be safely combined in expert centers with additional surgeries. Widespread change of practice not advices yet by the authors
Manuela Robella & @ISSPP1 study group
sciencedirect.com/science/ar…
First Franco-Swiss group of partners/experts patients with peritoneal pathology.#Pelopsproject
Now, patients can be included in the research projects.@oliviawriting @MartinHbner3 @ClaEveno @AssocAmarape @glehenolivier
Besoin de financement pour les projets: pathologie péritonéale #peritoine #organeoublie #musiciens #chanteurs #stars #ouetesvous @VianneyMusique @Sopranopsy4 @Slimaneoff @Tof_Beaugrand @nikosaliagas @Qofficiel @Nabilla
Intervention très intéressante du Dr @AT_surgery ce samedi à l' #AG2022 d' @AssocAmarape pour présenter le projet des patients partenaires dans la continuité de Véronique Rivoire démontrant le rôle important des patients dans le soin
#Pelops #cancer #RareDisease
AT retweeted
Intervention très intéressante du Dr @AT_surgery ce samedi à l' #AG2022 d' @AssocAmarape pour présenter le projet des patients partenaires dans la continuité de Véronique Rivoire démontrant le rôle important des patients dans le soin
#Pelops #cancer #RareDisease
☺️after my oral presentation about « patients reported outcomes for patients with peritoneal metastasis. #COMETE and PELOPS projects.@AssocAmarape @glehenolivier @oliviawriting – at Villeurbanne, France
Visual-abstract, PIPAC-Ox +5FU for PMc. @AnnSurgOncol @oliviawriting @AT_surgery @MartinHbner3 @bakrinna @ClaEveno @glehenolivier #🇫🇷 and🇨🇭 study.
Feasibility and Safety of Oxaliplatin-Based PIPAC +- Intraoperative IV 5-FU and Leucovorin for cPM: A Multicenter Comparative Cohort Study" has been published online in @AnnSurgOncol @oliviawriting @ClaEveno @bakrinna @MartinHbner3 @glehenolivier @dr_mohammadyami @BasilePache